Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-25-010120

President & COO sold 750,000 shares at an average $10.92 ($8,190,725)

  • President & COO acquired 1,002,311 shares (option exercise)
  • President & COO gave up 10,945 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & COO 2025-03-20 Shares withheld for taxes 10b5-1 −10,945 $10.97 $120,067 874,979 D
Venker Eric President & COO 2025-03-20 Option exercise 10b5-1 +400,000 $3.85 $1,540,000 1,274,979 D
Venker Eric President & COO 2025-03-20 Sale 10b5-1 −315,522 $11.06 $3,489,673 959,457 D
Venker Eric President & COO 2025-03-24 Option exercise 10b5-1 +602,311 $3.85 $2,318,897 1,561,768 D
Venker Eric President & COO 2025-03-24 Sale 10b5-1 −434,478 $10.82 $4,701,052 1,127,290 D
Derivatives
Venker Eric President & COO 2025-03-20 Option exercise · Stock Option (Right to Buy) 10b5-1 −400,000 10,526,234 D
Venker Eric President & COO 2025-03-24 Option exercise · Stock Option (Right to Buy) 10b5-1 −602,311 9,923,923 D
Open-market sales · 750,000 sh · avg $10.92 · $8,190,725
Loading xslF345X05/form4.xml…